The global pain management devices market will benefit from increasing regulatory approvals for neuromodulation devices in recent years. According to a report published by Fortune Business Insights, titled “Pain Management Devices: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at USD 3,922.9 Mn in 2018. Fortune Business Insights states that the market will reach USD 8,046.3 Mn by 2026, exhibiting a CAGR of 9.4%.
Pain management devices aid in reducing chronic pain and other undesirable conditions. Pain management can be used as an alternative to surgery to improve the result of your medication. This allows a non-invasive platform for surgical procedures, which in turn will lead to an increase in the market value. Recent technological advancements have opened up a huge pain management devices market growth potential.
According to the Centers for Disease Control and Prevention, around 20.4% of the total population in the US suffered from chronic pain in 2016. In addition to the increasing incidence of chronic pain, increasing neuropathic conditions will contribute to the increasing pain management devices market size.
“Launch of Technologically Advanced Pain Management Devices Likely to Enable Market Growth”
Technological advancements in pain management devices have played a huge part in the overall pain management market growth in recent years. Several companies have launched products with better feasibility and high operational efficacy. In January 2019, Boston Scientific announced the launch of an advanced chronic pain management device, which has been identified as one of the very few devices in the market with the ability to combine paresthesia and sub-perception therapy.
The ‘Spectra WaveWriter SCS System’ was launched with the aim of offering a non-drug therapeutic approach for people suffering from chronic pain. The report encompasses product launches, similar to Boston Scientific’s latest device and signifies the importance and impact of such devices on the market.
Top players in the pain management devices market:
• Boston Scientific Corporation
• DJO Global LLC
• SPR Therapeutics
• Nevro Corp
Order Full Report@ https://www.fortunebusinessinsights.com/checkout-page/101069
“35% Rise in Regulatory Approvals for Pain Management Device Indicates a Huge Potential for Growth in the Foreseeable Future”
As the benefits of pain management devices have been unfolded in recent years, there has been an increase in adoption for these devices across the world. Resulting from the increasing demand for pain management devices, there has been a gradual increase in clinical approvals for these devices in recent years.
According to the International Neuromodulation Society, the total number of approvals for neuromodulation devices from the Food and Drug Administration increased by approximately 35% in the past decade. Fortune Business Insights states that the growing usage approvals will favour the growth of the pain management devices market in the forthcoming years.
Table of Contents:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Recent Industry Developments- Partnerships, Mergers, and Acquisitions
4.2. Technological Advancements in Pain Management Devices Market
4.3. Epidemics of Chronic Pain for Key Countries
4.4. New Product Launch by Key Players
4.5. Key Industry Trends